Xuebing Cao

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Chronic pain, depression, and cognitive trajectories in Chinese middle-aged and older adults: A longitudinal cohort study.

Chronic pain, depression, and cognitive trajectories in Chinese middle-aged and older adults: A longitudinal cohort study.

Journal: Acta psychologica
Published: January 04, 2026

Disruption of axonal transport in Parkinson's disease: the role of pathological α-Syn and AMPK/p38 MAPK signaling.

Disruption of axonal transport in Parkinson's disease: the role of pathological α-Syn and AMPK/p38 MAPK signaling.

Journal: NPJ Parkinson's disease
Published: November 21, 2024

Alpha-synuclein Fibrils Inhibit Activation of the BDNF/ERK Signaling Loop in the mPFC to Induce Parkinson's Disease-like Alterations with Depression.

Alpha-synuclein Fibrils Inhibit Activation of the BDNF/ERK Signaling Loop in the mPFC to Induce Parkinson's Disease-like Alterations with Depression.

Journal: Neuroscience bulletin
Published: July 19, 2024

AMPK-mediated autophagy pathway activation promotes ΔFosB degradation to improve levodopa-induced dyskinesia.

AMPK-mediated autophagy pathway activation promotes ΔFosB degradation to improve levodopa-induced dyskinesia.

Journal: Cellular signalling
Published: January 22, 2024

Activation of mGlu2/3 receptors in the striatum alleviates L-DOPA-induced dyskinesia and inhibits abnormal postsynaptic molecular expression.

Activation of mGlu2/3 receptors in the striatum alleviates L-DOPA-induced dyskinesia and inhibits abnormal postsynaptic molecular expression.

Journal: Pharmacology, biochemistry, and behavior
Published: July 03, 2023

Identification of metabolism-related subtypes and feature genes in Alzheimer's disease.

Identification of metabolism-related subtypes and feature genes in Alzheimer's disease.

Journal: Journal of translational medicine
Published: May 19, 2023

Integrated PET/MRI With 11C-CFT and 18F-FDG for levodopa response difference in Parkinson's disease.

Integrated PET/MRI With 11C-CFT and 18F-FDG for levodopa response difference in Parkinson's disease.

Journal: Behavioural brain research
Published: April 20, 2023

Transcranial Magnetic Stimulation Alleviates Levodopa-Induced Dyskinesia in Parkinson's Disease and the Related Mechanisms: A Mini-Review.

Transcranial Magnetic Stimulation Alleviates Levodopa-Induced Dyskinesia in Parkinson's Disease and the Related Mechanisms: A Mini-Review.

Journal: Frontiers in neurology
Published: August 13, 2021

Characteristic of Parkinson's disease with severe COVID-19: a study of 10 cases from Wuhan.

Characteristic of Parkinson's disease with severe COVID-19: a study of 10 cases from Wuhan.

Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: August 04, 2020

Distinct anti-dyskinetic effects of amantadine and group II metabotropic glutamate receptor agonist LY354740 in a rodent model: An electrophysiological perspective.

Distinct anti-dyskinetic effects of amantadine and group II metabotropic glutamate receptor agonist LY354740 in a rodent model: An electrophysiological perspective.

Journal: Neurobiology of disease
Published: October 01, 2019

Initiation of Parkinson's disease from gut to brain by δ-secretase.

Initiation of Parkinson's disease from gut to brain by δ-secretase.

Journal: Cell research
Published: May 14, 2019

α-Synuclein stimulation of monoamine oxidase-B and legumain protease mediates the pathology of Parkinson's disease.

α-Synuclein stimulation of monoamine oxidase-B and legumain protease mediates the pathology of Parkinson's disease.

Journal: The EMBO journal
Published: December 19, 2017
Showing 1-12 of 16

Last Updated: 09/26/2026